AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find enclosed herewith Results Presentation for the Quarter and half year ended September 30, 2021 for your records.27-10-2021
27-10-2021
AARTI DRUGS LTD. - 524348 - Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2021
We wish to inform you that Board of Directors at its Meeting held on Wednesday, October 27, 2021, approved the Audited Standalone and Consolidated Financial Results for the Quarter and Half year ended September 30, 2021. Pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015 we enclose the following:- Audited Standalone and Consolidated Financial Results for the Quarter and Half year ended September 30, 2021. Standalone and Consolidated Statement of Assets and Liabilities. Standalone and Consolidated Cash Flow Statement. Auditor's Report on Standalone and Consolidated Financial Results for the Quarter and Half year ended September 30, 2021. Further, please note that the Company has already made necessary arrangement to publish the same in the Newspapers as required under the SEBI (LODR) Regulations, 2015.27-10-2021
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 read with Schedule III Part A Para A, Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Rule 22 of Companies (Management and Administration) Rules, 2014, other applicable provisions of the Companies Act, 2013 and SEBI Listing Regulations, we enclose the copies of newspaper advertisement published in The Financial Express (English) and Apla Mahanagar (Marathi), regarding the Postal Ballot Notice for seeking approval for appointment of Shri Ankit Vikram Paleja (DIN: 06975564) as an Independent Director of the Company.25-10-2021
AARTI DRUGS LTD. - 524348 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Please find attached the Postal Ballot Notice dated October 13, 2021, seeking approval of the members (by remote e-voting) for appointment of Shri Ankit Vikram Paleja (DIN: 06975564) as an Independent Director of the Company.23-10-2021
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
This is to inform you that Conference Call for the Investors and Analysts has been scheduled on Thursday, October 28, 2021 at 3:00 PM IST to discuss the Company's financial performance for the Quarter and half year ended September 30, 2021. Please find attached herewith invitation for the same.23-10-2021
Aarti Drugs Ltd - 524348 - Board Meeting Intimation for Audited Financial Results For The Quarter And Half Year Ended September 30, 2021.
AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2021 ,inter alia, to consider and approve Audited Financial Results for the Quarter and Half year ended September 30, 2021.20-10-2021
AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we inform you that the Company has issued Duplicate share certificates in lieu of original share certificates.13-10-2021
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that, based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors at its meeting held today appointed Shri Ankit Vikram Paleja (DIN: 06975564) as an Additional Director in the category of an Independent Director of the Company with effect from October 13, 2021 for the period of three years subject to approval of the Shareholders of the Company.13-10-2021
Aarti Drugs Ltd - 524348 - Shareholding for the Period Ended September 30, 2021
Aarti Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here11-10-2021
Aarti Drugs Ltd - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the Company has received information from Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company for Loss of share certificates10-10-2021